Patents expiring in 2029

US 7605161

Pyridyl derivatives and their use as therapeutic agents

Xenon Pharmaceuticals Inc. · Granted Tue Oct 20 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7605251

Compositions and methods for inhibiting expression of the PCSK9 gene

Alnylam Pharmaceuticals, Inc. · Granted Tue Oct 20 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7605174

Indane derivatives as modulators of ion channels

Vertex Pharmaceuticals Incorporated · Granted Tue Oct 20 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7608693

High affinity human antibodies to human IL-4 receptor

REGENERON PHARMACEUTICALS, INC. · Granted Tue Oct 27 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7608714

Production of dolasetron

TEVA Gyógyszergyár Zártkörüen Müködö Részvénytárasaság · Granted Tue Oct 27 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7608641

Creatine oral supplementation using creatine hydrochloride salt

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Oct 27 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7608683

Stress proteins and peptides and methods of use thereof

The Regents of the University of California · Granted Tue Oct 27 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7608627

6-azaindole compound

Takeda Pharmaceutical Company Limited · Granted Tue Oct 27 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7608422

Simian immunodeficiency virus (SIV) molecular clone encoding mutant gag gene lacking inhibitory/instability regions

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Oct 27 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7608261

VEGF antagonist formulations suitable for intravitreal administration

REGENERON PHARMACEUTICALS, INC. · Granted Tue Oct 27 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7608272

Methods and compositions for vaccination of animals with PRRSV antigens with improved immunogenicity

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Oct 27 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7608409

Screening assay using G-protein coupled receptor protein OT7T175

Takeda Pharmaceutical Company Limited · Granted Tue Oct 27 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7608449

Methods and compositions related to high-titer pseudotyped retroviruses

The Regents of the University of California · Granted Tue Oct 27 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7608253

Hydrolytically degradable carbamate derivatives of poly (ethylene glycol)

Nektar Therapeutics · Granted Tue Oct 27 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7608257

Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus

ONCOLYTICS BIOTECH INC. · Granted Tue Oct 27 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7608268

Ferritin fusion proteins for use in vaccines and other applications

New Century Pharmaceuticals, Inc. · Granted Tue Oct 27 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7608632

Sulfonamide inhibitors of aspartyl protease

Vertex Pharmaceuticals Incorporated · Granted Tue Oct 27 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7612203

Rosuvastatin and salts thereof free of rosuvastatin alkylether and a process for the preparation thereof

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Nov 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7612107

Treatment and inhibition of disease conditions using flexible heteroarotinoids

The Board of Regents of the University of Oklahoma · Granted Tue Nov 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7612188

Modified vitamin K. dependent polypeptides

Regents of the University of Minnesota · Granted Tue Nov 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7612065

Inhibitors of c-JUN N-terminal kinases (JNK)

Vertex Pharmaceuticals Incorporated · Granted Tue Nov 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7612073

Methods of administering tetrahydrobiopterin, associated compositions, and methods of measuring

BIOMARIN PHARMACEUTICAL INC. · Granted Tue Nov 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7612064

Sulfopyrroles

Takeda Pharmaceutical Company Limited · Granted Tue Nov 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7612037

Cross-linked glycopeptide-cephalosporin antibiotics

Theravance, Inc. · Granted Tue Nov 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7611885

Pharmaceutically compatible method for purifying intact bacterial minicells

EnGeneIC Molecular Delivery Pty Ltd · Granted Tue Nov 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7612093

Compositions of treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-D-glucitol compounds in combination therapy

United Therapeutics Corporation · Granted Tue Nov 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7612091

Caspase inhibitors and uses thereof

Vertex Pharmaceuticals Incorporated · Granted Tue Nov 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7612044

Melanoma antigens and their use in diagnostic and therapeutic methods

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Nov 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7611693

Mechanism-based targeted pancreatic beta cell imaging and therapy

The Board of Regents of the University of Texas System · Granted Tue Nov 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7611532

Coated implantable medical device

Cook Regentec LLC · Granted Tue Nov 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7611722

Dosage form with a core tablet of active ingredient sheathed in a compressed annular body of powder or granular material, and process and tooling for producing it

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Nov 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7611704

Compositions and methods for treating viral infections using antibodies and immunoconjugates to aminophospholipids

The Board of Regents of the University of Texas System · Granted Tue Nov 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7611728

Osmotic delivery of therapeutic compounds by solubility enhancement

Supernus Pharmaceuticals, Inc. · Granted Tue Nov 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7611533

Coated implantable medical device

Cook Regentec LLC · Granted Tue Nov 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7615230

Method for decreasing sebum production

Graceway Pharmaceuticals. LLC · Granted Tue Nov 10 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7615227

Use of CpG oligodeoxynucleotides to induce angiogenesis

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Nov 10 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7615220

High affinity human antibodies to human IL-18 receptor

REGENERON PHARMACEUTICALS, INC. · Granted Tue Nov 10 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7615223

Selected immunoconjugates for binding to aminophospholipids

The Board of Regents of the University of Texas System · Granted Tue Nov 10 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7615573

Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Nov 10 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7615618

Oligonucleotides comprising a non-phosphate backbone linkage

Alnylam Pharmaceuticals, Inc. · Granted Tue Nov 10 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7615208

Metal ion-labeled bis-aminoethanethiol-targeting ligand conjugates, compositions, and methods for tissue-specific disease imaging

The Board of Regents of the University of Texas System · Granted Tue Nov 10 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7615582

One-pack type adhesive composition for dental use

Kuraray Medical Inc. · Granted Tue Nov 10 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7615566

Substituted pyrrolidine and related compounds

Theravance, Inc. · Granted Tue Nov 10 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7619000

S-dimethylarsino-thiosuccinic acid S-dimethylarsino-2-thiobenzoic acid S-(dimethylarsino) glutathione as treatments for cancer

The Board of Regents of the University of Texas System · Granted Tue Nov 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7619057

MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7619112

Optical resolution of 3-carbamoylmethyl-5-methyl hexanoic acid

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Nov 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7619117

Rasagiline formulations and processes for their preparation

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Nov 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7618623

Hybrid adeno-retroviral vector for the transfection of cells

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Nov 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)